Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exocyst complex component 3-like protein 1 (EXOC3L1) is a protein involved in the exocyst complex, which is essential for vesicle trafficking and exocytosis[1][3][11]. It is predicted to enable SNARE binding activity and may play a specific role in the regulated exocytosis of insulin granules and peptide hormone secretion[1][3][4][10][11]. Expression of EXOC3L1 is most prominent in endothelial cell lineages[2]. While crucial in cellular secretory processes, it is not considered a typical therapeutic target such as a receptor, enzyme, or transporter[1][4][11]. No current evidence suggests established drug interactions, biomarker status, or significant safety issues in a therapeutic context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exocyst complex component 3-like protein 1 (EXOC3L1).